dedup-isc-ft-v107-score
float64
0.3
1
uid
stringlengths
32
32
text
stringlengths
1
17.9k
paper_id
stringlengths
8
11
original_image_filename
stringlengths
7
69
0.489714
c567811153a64427bef1906941bf400f
Proton Nuclear Magnetic Resonance Spectra of A AM-zein, B AM-zein-SA, and C SA
PMC9862550
12951_2023_1777_Fig6_HTML.jpg
0.479825
aad5ace4117f448580d3d64869e9b514
SEM images of A AM-zein, B AM-zein-SA, C EB@AM-zein, and D EB@AM-zein-SA
PMC9862550
12951_2023_1777_Fig7_HTML.jpg
0.457339
83d0e86cec844b669b77aa548a59e783
Particle size distribution of A-2 AM-zein, B-2 AM-zein-SA, C-2 EB@AM-zein, and D-2 EB@AM-zein-SA
PMC9862550
12951_2023_1777_Fig8_HTML.jpg
0.466944
4d76b83e687b4f0f90e1a9e883198ae8
The particle sizes of A EB@AM-zein and B EB@AM-zein-SA during storage. The experimental data were measured three replicates; a statistically significant difference between treatments compared with control is indicated by different small alphabets (a–d). Error bars indicate the least considerable value (LSD) at p ≤ 0.05 among the treatments
PMC9862550
12951_2023_1777_Fig9_HTML.jpg
0.418774
161ca12d352a4298a7a0595323a60e83
Photo of the sample S03 with the two artificial flaws (left: OF30%, right: OF70%). The transducer was scanned over the opposite side of the plate.
PMC9862802
materials-16-00506-g001.jpg
0.482365
49375e5083cb4ae9b54e60e57fda7128
Schematic view of the differential eddy current transducer and arrangement over the sample. EA, EB, EC, ED—excitation coils, S—pick-up coil, core—ferrite core, φx, φy—magnetic fluxes generated by the pairs of excitation coils.
PMC9862802
materials-16-00506-g002.jpg
0.468668
e38f974d2a754828bf988dc6f34e290b
Photo of the transducer protected by the tape (bottom view).
PMC9862802
materials-16-00506-g003.jpg
0.535949
cc6f161c78f24b0e9247badfc516e626
Measuring system.
PMC9862802
materials-16-00506-g004.jpg
0.387125
44a26c44a5c94a5e99eaec2b6825fa36
Relative voltage changes δu caused by the material influence plotted as a function of the excitation frequency f.
PMC9862802
materials-16-00506-g005.jpg
0.41575
a7f73068dc284dc4b2405ec43694b3ab
Relative voltages for various excitation frequencies as a function of sensor position (a) OF70%; (b) OF30%.
PMC9862802
materials-16-00506-g006.jpg
0.433632
3040cdaccecc4102967537ef5a59884d
Spectrograms of relative voltage (a) OF70%, (b) OF30%.
PMC9862802
materials-16-00506-g007.jpg
0.424507
e649dbb16241480d8d4703bc62624c29
Maximum relative voltages as a function of the excitation frequency. The red line approximates data for OF70%, while the blue line approximates data for OF30%.
PMC9862802
materials-16-00506-g008.jpg
0.428049
3353c4a0226f4fd6b82a914381b8c6c8
Two-dimensional plot of the relative voltage as a function of the sensor position; excitation frequency f = 2 MHz; a raw signal before background removal.
PMC9862802
materials-16-00506-g009.jpg
0.488026
3f4b9ad9bfe944a78f3f2cfd8e7b455d
Two-dimensional plots of the relative voltage as a function of sensor position; excitation frequency f = 2 MHz; the raw signals before background removal; (a) OF70%, (b) OF30%.
PMC9862802
materials-16-00506-g010.jpg
0.433944
68cc417978c64005851ecbb173dc82f5
Signal processing algorithm for the background signal removal.
PMC9862802
materials-16-00506-g011.jpg
0.479491
b85da63d1c4c48ce9c3a9eaab7f45d8e
Two-dimensional plots of the background signals estimated for the excitation frequency f = 2 MHz, which were utilized to correct signals measured for the flaw: (a) OF70%, (b) OF30%.
PMC9862802
materials-16-00506-g012.jpg
0.437309
8faf67acd3784f7eb60f20daaee5c3a5
Two-dimensional plot of the relative voltage after background removal; excitation frequency f = 2 MHz.
PMC9862802
materials-16-00506-g013.jpg
0.506593
29a2954dd6734ab19210217d988442a3
Two-dimensional plot of the relative voltage after background signal removal; excitation frequency f = 2 MHz; plot for the flaw: (a) OF70%, (b) OF30%.
PMC9862802
materials-16-00506-g014.jpg
0.426033
1fdbed18f1ad4f92831e61520cd672fd
Two-dimensional plot of the relative voltage after background signal removal; excitation frequency f = 2 MHz; plots of the signals measured for the same side flaws (inner flaws): (a) IF70%, (b) IF30%.
PMC9862802
materials-16-00506-g015.jpg
0.413728
60caeb2722c744b79b31b682c12f9970
Tencent Streetview pictures of downtown Guiyang (selected).
PMC9863786
ijerph-20-01646-g001.jpg
0.414592
4dcf5c484abc453094a039b2a377c5a4
Quantitative street space indicator interpretation map [48].
PMC9863786
ijerph-20-01646-g002.jpg
0.444616
ce41fd98fd744625888b5c0cbfb68cb2
Process of street space classification.
PMC9863786
ijerph-20-01646-g003.jpg
0.442219
557594bed5e3472e8d36cdb5d704048f
Identification of the type and level of grid vitality based on POI data.
PMC9863786
ijerph-20-01646-g004.jpg
0.428721
996a309371b145339ce04d46e1c6a5a1
Layout of vitality types against street space patterns.
PMC9863786
ijerph-20-01646-g005.jpg
0.458322
25e88df6b5a243b5af31f46110197bf6
Layout of vitality levels against different street space patterns.
PMC9863786
ijerph-20-01646-g006.jpg
0.418379
6023230158e140b19a7dac0d49416b2f
Selected gastrointestinal, oral, and nasal microbiome biomarkers and related diseases. Figure prepared by the authors.
PMC9864681
sensors-23-00837-g001.jpg
0.386528
540afa67d9084a499ab6a8caa53fed61
Amperometric detection principles of (A) an acetate biosensor using acetate kinase (AK), pyruvate kinase (PK), and pyruvate oxidase (POx), and (B) a propionate biosensor using propionate CoA-transferase (PCT) and short-chain acyl-CoA oxidase (SCAOx). Adapted from [34] with permission.
PMC9864681
sensors-23-00837-g002.jpg
0.387041
045b4a9776a44e7a9d1bb457ebb53689
(A) Schematic view of the microfluidic setup and sensing layer synthesis for the determination of SCFAs and (B) Nyquist spectra of the sensing layer at various concentrations of acetic acid and propionic acid in a mixture with 0.5 mg mL−1 butyric acid. Adapted from [35] with permission.
PMC9864681
sensors-23-00837-g003.jpg
0.412221
32f3e3ab08cb4a78ad9ec7336b62465d
(A) Microfluidic chip and holder, and the different components of the cartridge. (B) Scheme of the magneto-immunoassay format for the determination of MPO: (1) anti-MPO-biotin; (2) biotin used as blocker; (3) anti-MPO-HRP. Adapted from [59] with permission.
PMC9864681
sensors-23-00837-g004.jpg
0.453785
19b2e1d9dff846ed8856858a4d949bba
Schematic illustrations of: (A) the SPCE/AuNPs/Au-nano-dendroids/GO/anti-ALP probe for the determination of ALP in serum, and (B) the electrochemical assay of ALP activity based on the enzyme-catalyzed reaction. Adapted from [66,67], respectively, with permission.
PMC9864681
sensors-23-00837-g005.jpg
0.45396
3fd6f6f376834ff095802e451f0328f3
Illustrative schemes of: (A) the preparation procedure of PtNi@Cu-TCPP(Fe)-Ab2 bioconjugate, and (B) the construction of the sandwich immunosensor. Reprinted from [74] with permission.
PMC9864681
sensors-23-00837-g006.jpg
0.43574
e4f1d47b91394cc2975e4cb7cc71ecf8
Schematic illustrations of some electrochemical immunosensors for the determination of IL-8: (A) a sandwich-type immunoassay using a polyenzyme label on diaphorase (DI-3) and neutravidin; (B) the synthesis of β-Ag2-MoO4 NPs and immunoelectrode fabrication; (C) fabrication of an AuNPs-rGO based immunosensor; (D) steps for preparation of an impedimetric immunosensor. Reprinted from (A) [101], (B) [102]; (C) [103] and (D) [104] with permission.
PMC9864681
sensors-23-00837-g007.jpg
0.44236
9eeed87fb77b4caca9aa6a0cab03b190
Schematic of an electrochemical aptasensor for the simultaneous and real-time monitoring of VEGF, IFN-γ and TNF-α. Reproduced from [126] with permission.
PMC9864681
sensors-23-00837-g008.jpg
0.433813
0d92173781ec44a5a6e6a991014f5836
Power Analysis for Sample Size Adequacy.
PMC9864702
ijerph-20-01508-g001.jpg
0.398252
501ad6b7741b4d1ba66bd10a8ecf1c04
ROC curves for all three logistic regression models (DV1, DV2, and DV3).
PMC9864702
ijerph-20-01508-g002.jpg
0.399401
60f51a1b37e043c5a339e5bf26866387
Genetic screening for modulators of Aβ toxicity. (A) Mating GAL10-MFα-Aβ1–42-GFP strain with KO yeast collection. A yeast strain overexpressing MFα-Aβ1–42-GFP was mated with a yeast collection of 5154 mutants. A synthetic genetic array (SGA) was performed as indicated in the M&M section to obtain mutant KO yeasts that overexpress MFα-Aβ1–42-GFP. (B) Phenotype comparison with and w/o galactose (upper panels) and quantification with Cell Profile (lower panels).
PMC9865122
ijms-24-01278-g001.jpg
0.450242
8a9c0f6a922944e3bad224a8c1340f46
Expression of Aβ1–42 and its effect in yeast. (A) Aβ1–42 construct contains the mating factor α (MFα) pre-pro-leader sequence secretion signal at the N-terminal and a GFP tag at the C-terminal fused with a gly-ala linker (in brown). (B,C) Western blot analysis of Aβ1–42-GFP expression using an anti-GFP antibody (B) and representative Aβ1–42-GFP confocal images (C) in yeast transformed with wild-type (WT), Dutch or Arctic Aβ1–42 or with an empty vector (control) and cultured for 6 h at 30 °C in inducing (galactose) medium. A strain constitutively expressing GFP was used as a positive control. Glycosylated MFα-Aβ1–42-GFP is labelled as 1, non-glycosylated MFα-Aβ1–42-GFP is marked as 2 and Aβ1–42-GFP corresponds to 3. (D) Serial dilutions of yeast transformed with WT, Dutch or Arctic Aβ1–42 or with an empty vector (control) and spotted on inducing (galactose) and non-inducing (glucose) medium for 3 days at 30 °C. (E) Quantification of mean growth calculated after 3 days in inducing medium divided by the growth in non-inducing medium (Gal/Glu). Data are the mean ± SEM of 11–16 experiments. *** p < 0.001 vs. control, ## p < 0.01, # p < 0.05 vs. WT by ANOVA plus Bonferroni as post hoc test.
PMC9865122
ijms-24-01278-g002.jpg
0.424166
4132006f95964420b99c731edfc2cc90
Reactome pathway enrichment of the network created with the 238 mammalian orthologues. Enrichment ratios are given for each pathway. Enrichment ratios were obtained from WebGestalt.
PMC9865122
ijms-24-01278-g003.jpg
0.490686
cd6afa01faf34114be2fe388c288ea0f
Cluster with the highest MCODE score is shown in yellow. Amyloid toxicity protective genes can be seen in blue and enhancer genes can be seen in salmon.
PMC9865122
ijms-24-01278-g004.jpg
0.414195
e0ac47075b96447c8fb25bb7db657bee
Subnetwork of genes associated with SOCE and connected to SURF4.
PMC9865122
ijms-24-01278-g005.jpg
0.572203
0cacac6ee58e46eeaef59e391d3a9906
SURF4 contributes to Aβ1–42 toxicity on neuroblastoma cells. (A) Human neuroblastoma cells were transfected with SURF4 siRNA or with a non-active control siRNA, and after 48 h the levels of SURF mRNA were quantified by semi-quantitative rtPCR. Data are the mean ± SEM of 3 independent experiments. **** p < 0.0001 vs. control by Student’s t-test. (B,C) Cells transfected with SURF4 siRNA were treated with 5 µM (B) or 10 µM (C) oAβ1–42 for 24 h. Data are the mean ± SEM of 3–10 independent experiments. * p < 0.05 vs. control by Student’s t-test. (D) Human neuroblastoma cells were transfected with a plasmid containing the sequence of human SURF4 or with a non-coding control (pcDNA3), and after 48 h the levels of SURF mRNA were quantified by semi-quantitative rtPCR. Data are the mean ± SEM of 3 independent experiments. **** p < 0.0001 vs. control by Student’s t-test. (E,F) Cells transfected with the plasmid to overexpress SURF4 were treated with 5 µM (B) or 10 µM (C) oAβ1–42 for 24 h. Data are the mean ± SEM of 4 independent experiments. ** p < 0.01 and * p < 0.5 vs. control by Student’s t-test.
PMC9865122
ijms-24-01278-g006.jpg
0.435593
5e2eadbcaaa34de5becc523dda5ef2f6
SURF4 conditions SOCE activity. (A,B) Human neuroblastoma cells were transfected with SURF4 siRNA (A) or with a plasmid to overexpress SURF4 (B), and after 48 h the levels of calcium were measured by using FURA2. Data are the mean ± SEM of 4–7 independent experiments. *** p < 0.001 vs. control by Student’s t-test. (C,D) Cells transfected with SURF4 siRNA (C) or SURF4 plasmid (D) were exposed to 0 extracellular calcium, and intracellular Ca2+ changes in response to ER depletion by thapsigargin were measured using FURA2. Data are the mean ± SEM of 4–6 independent experiments. (E,F) Cells were transfected with SURF4 siRNA (E) or SURF4 plasmid (F) during 48 h, and SOCE activity (induced by ER Ca2+ release with thapsigargin) was evaluated with FURA2 following re-addition of Ca2+ to the bathing solution. Data are the mean ± SEM of 5–7 independent experiments. *** p < 0.001 vs. control by Student’s t-test.
PMC9865122
ijms-24-01278-g007.jpg
0.451872
0ea4148977f24293bfd33931554954f9
SURF4 affects SOCE proteins. (A) Neuroblastoma cells were treated with 10 µM oAβ1–42 in the presence of the SOCE inhibitor Ro for 24 h. Data are the mean ± SEM of 3 independent experiments. ** p < 0.01, non-significant (ns) vs. the respective controls by ANOVA plus Bonferroni as post-hoc test. (B) SOCE is dependent in the interaction of STIM, located in ER, with ORAI, located in the plasmatic membrane that opens to allow the entrance of calcium.
PMC9865122
ijms-24-01278-g008.jpg
0.448033
9eeb0bfda6374831b26fb20b42033688
Schematic illustration of the application of BC-based composite/blend scaffolds in various regenerative tissue engineering (Created with BioRender.com; accessed on 28 November 2022).
PMC9865793
ijms-24-00986-g001.jpg
0.405111
f907ba89832e4037a3af711fe2eff5dc
(a) The proposed mechanism of BC biosynthesis in K. xylinus using glucose and fructose as carbon sources and assembly of cellulose into nanofibrils. Glc; glucose, Glc-6-P; glucose 6 phosphate, Glc-1-P; glucose 1 phosphate, UDP-Glc; uridine diphosphoglucose (UDP-Glc), GC-6-P; gluconate 6 phosphate, Fru-6-P; fructose 6 phosphate, Fru; fructose, GK-ATP; ATP dependant glucokinase, PGM; Phosphoglucomutase, UGP; UDP–glucose pyrophosphorylase, G6PD; Glucose-6-phosphate dehydrogenase, PGI; phosphoglucoisomerase, FK; fructokinase and BCSC; bacterial cellulose synthase complex and (b) membrane-based cellulose synthase complex (Created with BioRender.com; access date 4 November 2022).
PMC9865793
ijms-24-00986-g002.jpg
0.438689
2d920962e6a8439abe64040740e567ef
(a) BC produced under the static conditions in Professor Roy’s laboratory, University of Sheffield, using the bacterial strain K. xylinus, (b) Purified BC.
PMC9865793
ijms-24-00986-g003.jpg
0.397487
5221c45951794cab8e3e92bafe54ce19
FTIR spectra and SEM micrographs; (i) FTIR of BC blended with natural rubber (NR) with varying NR composition, and FESEM micrograph for comparison (a) neat dried BC and (b) dried BC/NR blend, adapted from Potivara & Phisalapong [81]; and (ii) FTIR of BC/gelatin blend with neat BC and BC/gelatin blend (red arrows indicating signals from amide groups), with FESEM images comparison of (c) neat BC and (d) BC/gelatin blend, adapted from [82].
PMC9865793
ijms-24-00986-g004.jpg
0.449105
c98fde58386f4ef5b2f5c6b94339a4ab
SEM images of the morphology of HAp-BC composites, produced for bone tissue engineering. (a) control (pure BC) at ×10,000 magnification, (b) HAp-BC composites at ×10,000 magnification, and (c) HAp-BC composites at ×5000 magnification (adapted from Bayir et al. [121]).
PMC9865793
ijms-24-00986-g005.jpg
0.440758
222e15d8cb0c41bfaf10feb903ddb75d
SEM images showing different morphologies of freeze-dried pure BC and BC/Chitosan (BC/Ch) composites obtained by varying the chitosan content. Pure BC (a,b); BC/Ch-1% (c,d); BC/Ch-1.5% (e,f); BC/Ch-2% (g,h). All images were taken at 5000× magnification with the top row showing the cross section and the bottom row is the inner wall of the composites (Adapted from Li et al. [141]).
PMC9865793
ijms-24-00986-g006.jpg
0.425378
dac7effb5c5a4ab395ff1577baf49fa1
(a) Schematic representation of the process of incorporating growth factors into BC-based NGC and its implantation into a rat. (b) The digital photographs of the peripheral nerve regeneration, the BC conduits and transplantation at week 0, rat’s sciatic nerve regeneration at weeks 4 and 9 weeks post-surgery. Adapted from Wei et al. [156].
PMC9865793
ijms-24-00986-g007.jpg
0.445652
7eee444c7d9f4ed28c5cf944d522c1f0
Placement of a cellulose patch on the left ventricle of a Wistar rat. This study aimed to use BC membrane patches containing cocultured cells to limit myocardial postinfarction pathology. Adapted from [159,165].
PMC9865793
ijms-24-00986-g008.jpg
0.433805
d6602c75abde44ad85662bfbdcdced98
Implantation of BC/PCL and BC scaffolds in a rabbit’s cornea by a surgical technique (12× magnification). (a) Edge of the corneal trepanation (arrow). (b,c) Lamellar dissection. (d) Edge of complete superficial lamellar keratectomy (arrow). (e) Intrastromal insertion of spatula to produce a pocket. (f) Insertion of the membrane into the interlayer pocket; edge of corneal trepanation (black arrow); edge of the membrane inside the interlayer pocket (white arrow) (adapted from Sepulveda et al. [173]).
PMC9865793
ijms-24-00986-g009.jpg
0.432039
5687edcc793f4cec9c69de9bfbb8d1ae
Longitudinal incisions on the anterior wall of the common bile duct and implanted cellulosic exopolysaccharide biopolymer (ECB); a BC film. The appearance of implanted BC films reoperated after 330 days (a) and 150 days (b). Reprinted with permission from reference [178], copyright © 2020, SAGE publication.
PMC9865793
ijms-24-00986-g010.jpg
0.405171
97c9d214ffe043019b08e61134777877
Rat model of skin defects healing over time without (left side) or with bacterial cellulose scaffold covering (right side) (Adapted from Cheng et al. [188]).
PMC9865793
ijms-24-00986-g011.jpg
0.495812
32234d6115f6404e9fe9654a811608c2
Assay procedures and readouts. (A) Scheme of sample preparation for controls (yellow) and test samples (green) processed in parallel. (B) Representative chromatograms of two standards (CDCA and DCA) in blue and a blank buffer in red (top). Representative control sample in red showing natural levels of indicated BAs and control sample with spiked BAs in blue.
PMC9865816
microorganisms-11-00135-g001.jpg
0.394282
085d2db6b74c4007ba9cee83366ba5eb
Assay quantification and sensitivity in fecal matrix. (A) Limit of detection (LoD) and limit of quantification (LoQ) to upper limit of quantification (ULoQ) of the indicated BA highlighting the sensitivity of our method. (B) Inter- and Intra-day runs show high precision (%CV) and high accuracy of quality control samples. 3 independent experiments were run with each BA using a 4-point concentration gradient. (C) Detection of fecal BA after 0, 1, and 2 cycles of freeze–thaws.
PMC9865816
microorganisms-11-00135-g002.jpg
0.436379
d1336787644a4502badfc581506f91a6
Large-scale BA changes detected in rCDI patients treated with RBX2660. Heatmap of fecal BA levels (ng/g) in wet fecal matter from PUNCH CD2 trial participants. Each row is a single patient sample, with rows grouped by timepoints (at baseline or time post baseline) of when the stool samples were collected. Annotations in boxes above the heatmap include primary (light gray) and secondary (dark gray) BA, conjugate (green) and deconjugated (white) BA, as well as 7-hydroxylation (7-OH, blue), 7-oxo (7=O, red), and 7-dehydroxylated (7-H, tan) BA.
PMC9865816
microorganisms-11-00135-g003.jpg
0.443399
1d61ee47cb9242eb88dd02a5469135c8
Quantitative and specific BA changes. (A) Absolute fecal levels of the primary BAs TCA, GCA, CA known to promote C. difficile germination. (B) Absolute fecal levels of the secondary BAs LCA and DCA associated with suppression of C. difficile outgrowth. Samples from study participants were taken at baseline, week 1, week 4, and week 8 post RBX2660 treatment. Red line represents the geometric mean. Statistical significant was determined by a linear mixed model and the changes from baseline were significantly different for all BAs (p < 0.05).
PMC9865816
microorganisms-11-00135-g004.jpg
0.437883
5ea18faf14a848438b0b3dc20af36ebb
BA compositions over time. All detected bile acids were categorized and grouped as either primary or secondary and conjugated or deconjugated to highlight the average changes to fecal BA composition over the course of the study in rCDI patients receiving RBX2660.
PMC9865816
microorganisms-11-00135-g005.jpg
0.405702
d5f4c9f960824645be93ebb3ee497d9c
Basal cell carcinoma. RCM mosaic (1500 × 1500 µm2) showing elongated cord-like structures and tumor islands (*) of different sizes delineated by dark clefts (white arrowhead). Large canalicular blood vessels (red arrowhead). Sparse plump-bright cells representing melanophages (white circle) and numerous bright cells with thin dendritic structures corresponding to melanocytes (white arrows) within the tumor islands.
PMC9866322
ijms-24-01079-g001.jpg
0.432581
d0f1b6c0df044baabd02e3708a69cc61
Squamous cell carcinoma. RCM mosaic (1500 × 1500 µm2) showing atypical honeycomb pattern with broadened and irregular intercellular connections, pleomorphic keratinocytes, varying in size and shape and areas of total architectural disarray; scarce large, round, nucleated cells representing dyskeratotic cells (white arrows) and scattered small, bright inflammatory cells (white arrowheads).
PMC9866322
ijms-24-01079-g002.jpg
0.446633
10f7d4c136bd42b8ad8d66167610f4f9
Cutaneous melanoma. RCM mosaic (1500 × 1500 µm2) showing severe dermo-epidermal junction disarray and pleomorphic bright cells: large dendritic atypical cells (white arrows) with the tendency to form aggregates and roundish cells of different sizes in some areas forming scattered irregular clusters (white arrowheads), in others distributed in a diffuse pattern (white circle).
PMC9866322
ijms-24-01079-g003.jpg
0.425003
ff93f89270b4465b94204f498382b95f
The proposal for a more informed and improved fall risk assessment. (a) IMU mobility-based gait data are useful but lack contextual information. (b) As technology in wearable glasses becomes more advanced, they could be a viable option to provide more routine video capture to augment (and better inform) IMU data captured for mobility-based gait analysis. (c) Video data could provide absolute clarity on environment and why e.g., high (step time) variability may occur such as on uneven pavement in a poorly lit setting.
PMC9866998
sensors-23-00891-g001.jpg
0.437656
3bbb0eeb74ab4f91a503423e1e6afeb7
Example wavelet outputs from the bouts of walking captured during level ground asphalt walking phase with minima and maxima (peaks i.e., ICs and FCs) identified from CWT-based signals.
PMC9866998
sensors-23-00891-g002.jpg
0.470495
188d3d2ba8db41a4b6831157696c59eb
Spatio-temporal mobility-based gait characteristics from 30 s (≈57 steps) bouts of walking across the numerous terrain types. Here, we observed the greatest anomalies in the characteristics on terrains #4 (stair ascent, yellow) and #5 (stair descent, light blue). Typically, the remaining terrains present characteristics in what may appear to be normal fluctuations. Of note, the step length and step velocity in the lab bout (green) show some altered fluctuations and may be attributed to the protocol i.e., a walk in a looped (non-linear) circuit.
PMC9866998
sensors-23-00891-g003.jpg
0.444161
2d009c571a534faab11a62b6edd66790
Walking bout IMU processed and video data. (i) 30 s (from continuous 2 min loop) within a lab, (a) denoting the turns at the end of the track, (ii) level walking on asphalt with no clear abnormality in the IMU data but walking was in a linear path (i.e., straight line), (iii) walk from asphalt to paving and a step identified by the participant (red dot), with a possible anomaly in IMU-based data from visual observation denoted by (b and green squares), which roughly equates to the time of a single step from asphalt to paving, (iv) walking on paving and (c) at the latter stages of the 30 s walk as the participant stops before entering a revolving door, (v) stair ascent, noticeable changes in the CWT-based data as the participant walks up steps (d) and turns left (e) on the landing, and (vi) noticeable changes in the CWT-based data from level walking (f), stair descent (g), short steps to turn to next flight (h), stair descent (i) and level walking (j). The green rectangle in (v,vi) highlighting the similar fluctuations, as observed in (iii), due to stepping.
PMC9866998
sensors-23-00891-g004.jpg
0.384381
0582236d3acc4691a7acea842d798e5a
Left to right, although common algorithms for spatio-temporal processing for data collect on L5 are not specifically designed for e.g., stair ambulation, they may still be useful tools to help inform fall risk when used with video data for a more rounded mobility assessment.
PMC9866998
sensors-23-00891-g005.jpg
0.463413
53dda44007ad49669adb36d5e4c7a786
Electrical responses of sensors incorporating (a) MWCNTs, (b) rGO, (c) PANI, (d) rGO + PANI, (e) MWCNTs + PANI to ammonia vapors at a constant temperature of (24.0 ± 0.6) °C and humidity (6.3 ± 1.4)%.
PMC9867172
polymers-15-00420-g001a.jpg
0.383806
4be9d540a54d4369b985b707de732ebb
Electrical response of sensors incorporating (a) PANI + PS and (b) MWCNTs + PANI + PS in fatigue tests for exposure to ammonia vapors.
PMC9867172
polymers-15-00420-g002.jpg
0.431847
181d63cd7a654d2e9b05dd44233f369c
Electrical response of a PANI sensor at 26 °C and 70% humidity (a) without ammonia vapors and (b) with ammonia vapors.
PMC9867172
polymers-15-00420-g003.jpg
0.441836
b61d85df9dc24d04ba2eedb49abd63e8
Electrical response of a MWCNTs + PANI sensor at 26 °C and 70% humidity (a) without ammonia vapors and (b) with ammonia vapors.
PMC9867172
polymers-15-00420-g004.jpg
0.442303
7a302129bb904882afdc55234885d771
Electrical response of a PANI sensor at 30 °C and 80% humidity (a) without ammonia vapors and (b) with ammonia vapors.
PMC9867172
polymers-15-00420-g005a.jpg
0.455762
688a2dc3eae749018398d9219a812f3d
Electrical response of a MWCNT + PANI sensor at 30 °C and 80% humidity (a) without ammonia vapors and (b) with ammonia vapors.
PMC9867172
polymers-15-00420-g006a.jpg
0.45563
a94a39feeb7247faa2e9d2a5e34c97fe
Electrical response of a PANI sensor at 35 °C and 90% humidity (a) without ammonia vapors and (b) with ammonia vapors.
PMC9867172
polymers-15-00420-g007a.jpg
0.450895
da01e9eaa15d40c9bd0989f26174ae03
Electrical response of a MWCNTs + PANI sensor at 35 °C and 90% humidity (a) without ammonia vapors and (b) with ammonia vapors.
PMC9867172
polymers-15-00420-g008a.jpg
0.367874
f451de2f498b417d9f9d0a74358fdb2f
Time trends of population, stability, excretion rate, and uncertainty analysis studies
PMC9867605
11356_2023_25237_Fig1_HTML.jpg
0.492786
1f4ab32ce2bb4947a95f50257fea6060
High-frequency keywords
PMC9867605
11356_2023_25237_Fig2_HTML.jpg
0.407193
6a6e1530463e4d608971b2b68f522959
Time trend graph based on keyword frequency (keywords rendered by the orange and green colors are more likely to be trending up and trending down, respectively; the size of bubble reflects the total word frequency of the keyword)
PMC9867605
11356_2023_25237_Fig3_HTML.jpg
0.435698
a00c453ddd6745c5b1921589c255b92e
Comparison of antibody response in different peasant association (kebeles).
PMC9868296
fvets-09-1089931-g0001.jpg
0.456788
d660481b8ac043f9929c6625ee4a3724
Comparison of antibody response in different chicken in breeds.
PMC9868296
fvets-09-1089931-g0002.jpg
0.501029
ba17ff1cc22e47109f90dec955edca36
Inclusion and exclusion criteria. *PUMCH, Peking Union Medical Collage Hospital; NIA-AA, National Institute on Aging and Alzheimer's Association; MMSE, Mini-Mental State Examination; MoCA, Montreal Cognitive Assessment; EO(LO)AD, early-onset (late-onset) Alzheimer's disease; EO(LO)NAD, early-onset (later-onset) non-Alzheimer dementia; EO(LO)C, early-onset (late-onset) control; ALS, amyotrophic lateral sclerosis; CAA, cerebral amyloid angiopathy.
PMC9868908
fneur-13-1030019-g0001.jpg
0.437094
c7272585b5974d1bb944e90bf4a51f99
Comparison of CSF biomarker levels across groups. (A–E) Display Aβ42, t-tau, p-tau, t-tau/Aβ42, p-tau/Aβ42 distributions of the three groups respectively. Box plots present median and interquartile range and whiskers indicate 10–90% interval. In graph (D, E) asterisk markers (*) on X axis indicate that there is an outlier value beyond the upper limit. ADD, AD dementia; NADD, non-AD dementia. **P < 0.01; ***P < 0.001; ****P < 0.0001, between the two groups linked.
PMC9868908
fneur-13-1030019-g0002.jpg
0.443492
7a6640c0ecfe465390e383d900c74e55
ROC curves of CSF biomarkers in the early-onset group. (A, C) depict curves of the original biomarkers. (B, D) Display the curves of the calculated ratios and the generated predicting factor, respectively. Diagnostic accuracy, the area under the curve (AUC), is labeled in the legend.
PMC9868908
fneur-13-1030019-g0003.jpg
0.434759
f32a2ee792f84497813d990983087fe7
Document screening flow chart.
PMC9868924
fnins-16-1088448-g001.jpg
0.405182
3b1dbe665d7d44d4a69b1c38cf27a255
(A) Types of publications in the field of cerebral revascularization. (B) Trends in the volume of publications in the field of cerebral revascularization.
PMC9868924
fnins-16-1088448-g002.jpg
0.448703
9f6b219465774425bead4744b4b5847d
Analysis of countries and institutions. (A) Visual map of national collaboration based on CiteSpace software. (B) Visual map of institutions based on CiteSpace software. Each node represents a country/institution, and each connecting line represents the central cooperativeness between countries/institutions. The thicker the line, the closer the cooperation between countries/institutions.
PMC9868924
fnins-16-1088448-g003.jpg
0.455011
6a3c99d0b0d74bf183182a20b7a93cf0
Analysis of authors published the most articles based on the CiteSpace visual map. Each node represents an author’s name, and each line represents the central collaboration between authors. The thicker the line, the closer the collaboration between the authors.
PMC9868924
fnins-16-1088448-g004.jpg
0.479986
2a0e4c5b3deb4636a7a8ac451e793330
Author analysis. (A) Author collaborative network analysis based on VOSviewer visual map. (B) Co-citation author network analysis based on VOSviewer visual map. The clusters of different colors reflect the cooperation among authors.
PMC9868924
fnins-16-1088448-g005.jpg
0.445671
a6454137889c496e868acba4c46de846
Analysis of co-cited journals. (A) Network diagram of co-cited journals based on VOSviewer visual map. (B) Visualization of the density of co-cited journals based on VOSviewer visual map. Different color clustering reflects the cooperation between co-cited journals.
PMC9868924
fnins-16-1088448-g006.jpg
0.410303
1266a399aa634155b7977b8615853c7d
Keyword analysis. (A) Keyword network map based on Citespace visualization. Each node represents a keyword and each line represents the central cooperation relationship between keywords. (B) Keyword analysis based on the VOSviewer visual map. The clusters of different colors reflect the interrelationship between keywords.
PMC9868924
fnins-16-1088448-g007.jpg
0.479014
60de3ab88ac74f32b7e0e19476b09f2a
Visualization of keyword views. (A) Time zone view. (B) Timeline view.
PMC9868924
fnins-16-1088448-g008.jpg
0.427125
5ddae1260f3c40e4be2e9fa20d29e161
Analysis of cited articles and co-cited references. (A) Network diagram of cited articles based on VOSviewer visual map. (B) Network diagram of co-cited references based on VOSviewer visual map. Different color clustering reflects the close relationship between cited articles and co-cited references.
PMC9868924
fnins-16-1088448-g009.jpg
0.427987
e881609f99174211ad0ddaa0715759df
Novice actors’ changes with the progression of Repetition training in the number of each kind of utterance per session (*p < 0.05).
PMC9869025
fpsyg-13-949209-g001.jpg
0.354692
d2eebf08c4c7401498e61ad3a4ce3fbf
Difference between professional and novice actors in each kind of utterance per session (*p < 0.05), respectively for executors (A) and observers (B).
PMC9869025
fpsyg-13-949209-g002.jpg
0.417562
204f79eb6e39418f96f7117de8568c26
Antibody response after the first dose of Ad26.COV2.S and after eligibility for additional doses. In the box plot (A), the range (error bars), interquartile range (rectangle), median (horizontal line), and mean (x) antibody indices are depicted. Categorical results are presented in graph B. When more than one measurement was available during a given time period, the latest value was used. Measurements < 0.5 and > 750 index were included in the calculation as 0.5 and 750, respectively. For the “early” group, the assessment was completed a median of 96 days after primary vaccination. For the “late” antibody assessments, the last follow-up assessment was completed a median of 327 days after the primary vaccination for the Ad26.COV2.S group, a median of 89 days after the booster in the Ad26.COV2.S + Ad26.COV2.S and Ad26.COV2.S + mRNA groups, and a median of 21 days after the second booster in the Ad26.COV2.S + mRNA + mRNA group
PMC9869304
40620_2022_1559_Fig1_HTML.jpg
0.377951
5c6328696b914a3cb0df8bef2bc831d8
natural carbon quantum dots (NCQDs) synthesis from orange pericarp
PMC9869888
IJBMS-26-190-g001.jpg
0.595945
e77657cc386345cab6f95c33a9588107
FTIR spectra of the raw and natural carbon quantum dots (NCQDs) samples
PMC9869888
IJBMS-26-190-g002.jpg
0.562519
31bd25651e2b4c8fa4523c0c45c7e030
XRD pattern of the synthesized natural carbon quantum dots (NCQDs)
PMC9869888
IJBMS-26-190-g003.jpg
0.50675
55a6d1865b6b48cabe775fd91c669950
TGA and DTG curves of the raw and NCQDs samples under an air atmosphere at 10 °C/min heating rate
PMC9869888
IJBMS-26-190-g004.jpg
0.473657
1a4c444c28474a6ebf042fdd57800c20
(a) Dynamic light scattering (DLS) and (b) Zeta potential value of NCQDs
PMC9869888
IJBMS-26-190-g005.jpg